These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Dynamics of the dopaminergic system as a key component to the understanding of depression. Yadid G; Friedman A Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037 [TBL] [Abstract][Full Text] [Related]
6. [Depression and neuroplasticity]. Pitchot W; Polis M; Belachew S; Ansseau M Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207 [TBL] [Abstract][Full Text] [Related]
7. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. Koo MS; Kim EJ; Roh D; Kim CH Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383 [TBL] [Abstract][Full Text] [Related]
8. Dopaminergic-based pharmacotherapies for depression. Papakostas GI Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172 [TBL] [Abstract][Full Text] [Related]
9. [Striatal dopaminergic mechanisms and the specific activity of antidepressants]. Arushanian EB; Shchetinin EV Eksp Klin Farmakol; 1994; 57(3):60-4. PubMed ID: 8049623 [No Abstract] [Full Text] [Related]
10. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
14. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Jentsch JD; Roth RH; Taylor JR Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661 [TBL] [Abstract][Full Text] [Related]
15. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants]. Arantes-Gonçalves F; Coelho R Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439 [TBL] [Abstract][Full Text] [Related]
16. Dopamine is involved in the antidepressant-like effect of allopregnanolone in the forced swimming test in female rats. D'Aquila PS; Canu S; Sardella M; Spanu C; Serra G; Franconi F Behav Pharmacol; 2010 Feb; 21(1):21-8. PubMed ID: 20009921 [TBL] [Abstract][Full Text] [Related]
17. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Ressler KJ; Nemeroff CB Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410 [TBL] [Abstract][Full Text] [Related]
18. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Kiss JP Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein M; Deutch AY FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713 [TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test. Basso AM; Gallagher KB; Bratcher NA; Brioni JD; Moreland RB; Hsieh GC; Drescher K; Fox GB; Decker MW; Rueter LE Neuropsychopharmacology; 2005 Jul; 30(7):1257-68. PubMed ID: 15688083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]